Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19

URN to cite this document:: urn:nbn:de:bvb:355-epub-459880
DOI to cite this document:: 10.5283/epub.45988

Vogel, Manuel J. ; Mustroph, Julian ; Staudner, Stephan T. ; Leininger, Simon B. ; Hubauer, Ute ; Wallner, Stefan ; Meindl, Christine ; Hanses, Frank

; Zimmermann, Markus ; Maier, Lars S. ; Jungbauer, Carsten G. ; Hupf, Julian

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(868kB)

Date of publication of this fulltext: 15 Jun 2021 04:47

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Springer.

Details

Preview

Indexed in

Export bibliographical data

Abstract

Aims The aim of the current study was to evaluate whether tubular markers kidney injury molecule-1 (KIM-1) and N-acetyl-beta-glucosaminidase (NAG) are related to acute kidney injury (AKI) and severe disease in patients with COVID-19. Methods and results In this prospective observational clinical trial we examined a cohort of 80 patients with proof of acute respiratory infection and divided them ...